A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

This study has been terminated.
(This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.)
Sponsor:
Information provided by (Responsible Party):
UCB, Inc. ( UCB S.A. - Pharma Sector )
ClinicalTrials.gov Identifier:
NCT01883011
First received: June 18, 2013
Last updated: August 28, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2001
  Primary Completion Date: July 2001 (Final data collection date for primary outcome measure)